(Q39427020)

11 September 2017

title

The efficacy of divalproex sodium in the prophylactic treatment of children with migraine (English)

1 reference

11 September 2017

1 reference

Caruso JM

1

1 reference

11 September 2017

Brown WD

series ordinal

2

1 reference

11 September 2017

Exil G

series ordinal

3

1 reference

11 September 2017

Gascon GG

series ordinal

4

1 reference

11 September 2017

publication date

1 September 2000

1 reference

11 September 2017

1 reference

11 September 2017

volume

40

1 reference

11 September 2017

issue

8

1 reference

11 September 2017

page(s)

672-676

1 reference

Diagnoses and symptom patterns in children presenting to a pediatric headache clinic

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2000.040008672.X

Applicability of the 1988 IHS criteria to headache patients under the age of 18 years attending 21 Italian headache clinics. Juvenile Headache Collaborative Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2000.040008672.X

Classification of pediatric migraine: proposed revisions to the IHS criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2000.040008672.X

Chronic recurrent headaches in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2000.040008672.X

Pharmacologic treatment of childhood migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2000.040008672.X

A differential response to treatment with divalproex sodium in patients with intractable headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2000.040008672.X

Divalproex sodium in migraine prophylaxis: a dose-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2000.040008672.X

Migraine prophylaxis with divalproex

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2000.040008672.X

Divalproex sodium in headache: literature review and clinical guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2000.040008672.X

Valproate: a new drug in migraine prophylaxis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2000.040008672.X

Sodium valproate in the prophylactic treatment of migraine: a double-blind study versus placebo

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2000.040008672.X

Sodium valproate has a prophylactic effect in migraine without aura: a triple-blind, placebo-controlled crossover study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2000.040008672.X

Possible mechanisms of valproate in migraine prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2000.040008672.X

10.1046/J.1526-4610.2000.040008672.X

21 January 2018

Identifiers

DOI

1 reference

11 September 2017

1 reference